Private sector COVID Avalon Laboratories launched COVID testing for the private sector, signaling demand for rapid public health testing capabilities and potential for expanded diagnostic service contracts or private-label testing opportunities.

Acquisition history Now under Nordson MEDICAL since 2014, the company may offer co-selling or integration opportunities with Nordson’s device platforms, enabling cross-sell of diagnostics, test kits, or related medical devices to a broader customer base.

Moderate revenue With revenue in the low tens of millions, there is room for scalable growth through expanded product lines, contract manufacturing, or service agreements with larger laboratories needing nimble partners for specialized testing.

Mid-size lab dynamics Small-to-mid-sized operation (~11-50 employees) often seeks flexible, rapid-delivery partnerships, enabling targeted outreach for collaboration on consumables, workflow optimization tools, and turnkey testing services.

Competitive landscape In a field with major players like ARUP, Mayo Clinic Laboratories, and Quest Diagnostics, Avalon can pursue niche differentiation through private-sector testing, faster turnaround, and integration-friendly solutions tailored to private healthcare providers.